The Michael J. Fox Foundation for Parkinson's Research
Overview
The Michael J. Fox Foundation for Parkinson's Research is the world's largest nonprofit funder of Parkinson's research, dedicated to finding a cure and developing improved therapies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| MapLight Therapeutics | Aug 2021 | Grant | Co-investor |
| Mission Therapeutics | Jul 2024 | Grant | Co-investor |
| Acurex Biosciences | May 2026 | Grant | Co-investor |
| Nine Square Therapeutics | Sep 2023 | Grant | Co-investor |
| Erisyon | May 2020 | Grant | Co-investor |
For institutional investors. Book with your work email.
Key People
Thomas F.
Team Fox Boston Co-founder Advisor
Deborah Brooks
Co-Founder And CEO
Rachael Bulmer
Vice President, Head Of Principal Giving
Beatriz Portillo
Complex Principal Gifts Specialist
Katharina Klapper
Principal Clinical Research
Rachel Dolhun
Principal Medical Advisor
Alexandra Vaiana
Senior Scientific Portfolio Manager, Translational Research Programs
Barbara Marebwa
Senior Scientific Portfolio Manager
Hallie Wald Roach
Senior Scientific Portfolio Manager
Kendra Lechtenberg
Senior Scientific Portfolio Manager
Zimple Kurlawala
Senior Scientific Portfolio Manager
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is The Michael J. Fox Foundation for Parkinson's Research based?
The Michael J. Fox Foundation for Parkinson's Research is headquartered in New York City, New York, United States.
When was The Michael J. Fox Foundation for Parkinson's Research founded?
The Michael J. Fox Foundation for Parkinson's Research was founded in 2000.
How many portfolio companies does The Michael J. Fox Foundation for Parkinson's Research have?
The Michael J. Fox Foundation for Parkinson's Research has 74 portfolio companies in Caplight's dataset.
What are some companies in The Michael J. Fox Foundation for Parkinson's Research's portfolio?
Portfolio companies visible on Caplight include MapLight Therapeutics, Mission Therapeutics, Acurex Biosciences, Nine Square Therapeutics, Erisyon.
What was The Michael J. Fox Foundation for Parkinson's Research's most recent investment shown here?
The Michael J. Fox Foundation for Parkinson's Research's most recent investment in this portfolio sample was in Acurex Biosciences in 2026.
What sectors does The Michael J. Fox Foundation for Parkinson's Research focus on?
The Michael J. Fox Foundation for Parkinson's Research focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Enterprise Software, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does The Michael J. Fox Foundation for Parkinson's Research focus on?
The Michael J. Fox Foundation for Parkinson's Research typically invests at the MultiStage stage.
What is The Michael J. Fox Foundation for Parkinson's Research's AUM?
The Michael J. Fox Foundation for Parkinson's Research's assets under management are estimated between $439.0M and $439.0M.